Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

3 ETFs to Double Up On Right Now
3 ETFs to Double Up On Right Now

The market continues to climb higher, but some ETFs have not been partaking in all the gains yet still look intriguing moving forward. Each of these ETFs provides a unique look at the stock market

Bargains or Busts? These 3 Dividend Stocks Pay More Than 4% and Are Trading Near Their 52-Week LowsPhoto, wide shot, wide-angle lens, soft focus,  Railroad company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-PDBQn2GCVZs3frHaK2lGsDOa.png?st=2023-05-03T06%3A32%3A47Z&se=2023-05-03T08%3A32%3A47Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-02T19%3A53%3A01Z&ske=2023-05-03T19%3A53%3A01Z&sks=b&skv=2021-08-06&sig=B8RNBNOp5bAAUbGicg4q74TKunz53L%2BT3UK9Oi3oX%2B4%3D
Bargains or Busts? These 3 Dividend Stocks Pay More Than 4% and Are Trading Near Their 52-Week Lows

It's been a good year for the stock market as a whole, with the S&P 500 rising by 14% year to date (as of Sept. 22) and hitting new highs along the way. There have, however, also been no shortages

This Beaten-Down AI Stock Could Stage a Monster Comeback by 2028Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
This Beaten-Down AI Stock Could Stage a Monster Comeback by 2028

ASML Holding (NASDAQ: ASML) is one of the most important players in the global semiconductor industry. The Dutch semiconductor equipment giant manufactures machines that play a critical role in

Should You Buy Ford While It's Below $13?Photo, wide shot, wide-angle lens, soft focus,  Auto parts supplier, sunset photo at golden hour, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-ZpZWLOA2q1Lrbc78ceLTs90l.png?st=2023-05-15T05%3A50%3A02Z&se=2023-05-15T07%3A50%3A02Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T21%3A19%3A00Z&ske=2023-05-15T21%3A19%3A00Z&sks=b&skv=2021-08-06&sig=aAZzsKm3Fg0e2CB07XvcACW5j1LlZPrsv8bXoWdHs6k%3D
Should You Buy Ford While It's Below $13?

Ford (NYSE: F) has likely been on the radar of many investors lately as the company recently announced plans to launch an entirely new electric vehicle platform. Its aim is to boost profitability

This Company Has Bought $16 Billion of Its Own Stock -- Should You?Photo, wide shot, wide-angle lens, soft focus,  Car manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YEvJ4lsD0cnHYMSisqF0KmhC.png?st=2023-12-29T13%3A52%3A04Z&se=2023-12-29T15%3A52%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-12-29T03%3A19%3A21Z&ske=2023-12-30T03%3A19%3A21Z&sks=b&skv=2021-08-06&sig=cgEmp8qYLk6LiC9uwJEp9XOt32ky3AObpdzG41upqzc%3D
This Company Has Bought $16 Billion of Its Own Stock -- Should You?

It's challenging to find diamonds in the rough in the markets, because investors are smart and investment knowledge is everywhere. But one such opportunity exists in the least likely place for

Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock?Photo, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock?

In the pharmaceutical world, if you can't develop 'em, acquire 'em. That seems to be the philosophy behind Pfizer's (NYSE: PFE) latest big-ticket buy, specifically its purchase of clinical-stage

Why Iren Stock Surged Higher This WeekPhoto, wide shot, wide-angle lens, soft focus,  Gas company, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-tcjRuj5bqFkp1mtfRW3UniKc.png?st=2023-05-05T12%3A32%3A34Z&se=2023-05-05T14%3A32%3A34Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-05T04%3A49%3A27Z&ske=2023-05-06T04%3A49%3A27Z&sks=b&skv=2021-08-06&sig=BKOkdc9cKdFUkBJnHork/AsFKQ6z1sIxTLjeoW/ivEM%3D
Why Iren Stock Surged Higher This Week

Iren Limited (NASDAQ: IREN) is catching the attention of Wall Street analysts. Several new notes came out this week supporting the buy case for Iren stock.

Demand for the services of the data center

Why Did Direct-to-Consumer Retailers Stumble?
Why Did Direct-to-Consumer Retailers Stumble?

In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When

Should You Buy Chainlink While It's Under $53?
Should You Buy Chainlink While It's Under $53?

Chainlink (CRYPTO: LINK), a blockchain focused on aggregating real-world data, was created in 2017. It launched its native Link token in an initial coin offering (ICO) that September, and it started

Is Micron Stock the Best Buy Now?Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Is Micron Stock the Best Buy Now?

Micron Technology (NASDAQ: MU) has proved to be one of the biggest winners of the global artificial intelligence (AI) infrastructure buildout. While semiconductor companies like Nvidia and Broadcom

Rule Breaker Investing Mailbag: The House That Netflix BuiltPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Rule Breaker Investing Mailbag: The House That Netflix Built

In this podcast, Motley Fool co-founder David Gardner talks about a listener who says he invests $100 for each of his daughters' birthdays, positioning them for success in their financial futures

Why Strategy Stock Was Sinking This Week:
Why Strategy Stock Was Sinking This Week

Across the past several trading sessions, a wise investment strategy would have been to avoid shares of Strategy Inc. (NASDAQ: MSTR). The institutional Bitcoin investor's stock was off by almost

Underappreciated Rule-Breaking Small-Cap Stocks
Underappreciated Rule-Breaking Small-Cap Stocks

In this podcast, Motley Fool analyst Emily Flippen and contributors Jason Hall and Toby Bordelon dive into:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast

Domino's Isn't Just Selling Pizza. It's Building a Global PlatformPhoto, wide shot, wide-angle lens,  Fashion store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.theapi.app/temp/4103ce22-87d6-4bef-ba44-0baf5ab280bb.png
Domino's Isn't Just Selling Pizza. It's Building a Global Platform

Domino's Pizza (NASDAQ: DPZ) may be best known for late-night delivery, but for investors it represents something bigger. One of the most durable growth stories in the restaurant industry. Over the

Why Firefly Aviation's Stock Was Nose-Diving This Week
Why Firefly Aviation's Stock Was Nose-Diving This Week

Firefly Aviation (NASDAQ: FLY), a space stock that arrived recently to the market, was plummeting over the past few trading sessions. According to data compiled by S&P Global Market Intelligence its

Should You Buy Dogecoin Right Now?
Should You Buy Dogecoin Right Now?

Cryptocurrencies are always roller-coaster investments, but one that's taken dedicated investors to lofty peaks and -- at times almost as quickly -- punishing lows is Dogecoin (CRYPTO: DOGE).

The

Why CytomX Therapeutics Stock Was Skyrocketing This WeekPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Why CytomX Therapeutics Stock Was Skyrocketing This Week

It isn't difficult for a modestly priced stock to leap in value on a positive news item. That's the dynamic behind the monster rise these past few days of clinical-stage biotech CytomX Therapeutics

Should You Buy ARK 21Shares Bitcoin ETF (ARKB) While It's Under $40?:
Should You Buy ARK 21Shares Bitcoin ETF (ARKB) While It's Under $40?

Cryptocurrency headlines can be tiresome. Who cares if Bitcoin (CRYPTO: BTC) is worth $100,000 or $120,000 per coin, right? Both figures are enough to cover four years of college tuition, or buy a

A Healthcare Debate: Progyny vs. Hims & HersPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
A Healthcare Debate: Progyny vs. Hims & Hers

In this podcast, Motley Fool analysts Alicia Alfiere, Sanmeet Deo, and Tim Beyers discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're

Why Upstart Holdings Stock Was Trading Down This Week
Why Upstart Holdings Stock Was Trading Down This Week

A researcher reported that there has been a notable rise in short interest with loan marketplace Upstart (NASDAQ: UPST). Since that nugget of information hit the market on Tuesday, the company's

Is D-Wave Quantum Stock Still a Buy?
Is D-Wave Quantum Stock Still a Buy?

Quantum computing stocks have become Wall Street's favorite speculation, and D-Wave Quantum (NYSE: QBTS) epitomizes the subsector's promise and peril. The stock has rocketed 213% year to date

Coca-Cola Stock Sell-Off: Should You Buy the Dip?
Coca-Cola Stock Sell-Off: Should You Buy the Dip?

Coca-Cola (NYSE: KO), which has a roughly 3% dividend yield on its stock, is a company that just about everyone on planet Earth knows. That's a statement to how well run a business it is, which is

MercadoLibre Is the Amazon of Latin America ... or Is It?Photo, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
MercadoLibre Is the Amazon of Latin America ... or Is It?

When investors talk about MercadoLibre (NASDAQ: MELI), the phrase that comes up almost automatically is "the Amazon (NASDAQ: AMZN) of Latin America." The comparison isn't wrong. MercadoLibre runs

Is There a Future for XRP?:
Is There a Future for XRP?

After spending years below $1, XRP (CRYPTO: XRP) has skyrocketed over the last year, gaining 385% (as of Sept. 23). That's far better than Bitcoin, Ethereum, and every other top 10 cryptocurrency.

Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?

Johnson & Johnson (NYSE: JNJ) is a longtime healthcare leader with numerous positive qualities. These include its 62 consecutive years of dividend increases, which surpass the 50 required to be